Market News

Breaking headlines and analysis across every asset class.

Earnings
MarketBeat • Sep 4, 2026
ResMed (NYSE:RMD) Director Peter Farrell Sells 970 Shares

ResMed (NYSE:RMD) Director Peter Farrell sold 970 shares of the company's stock for $227,688.10 on September 2nd, reducing his position by 1.84%. Following the sale, he now owns 51,803 shares valued at over $12 million. The company recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend to $0.66 per share.

Earnings
MarketBeat • Sep 4, 2026
Tyler Technologies (NYSE:TYL) Stock Rating Lowered by Zacks Research

Zacks Research downgraded Tyler Technologies (NYSE:TYL) from "strong buy" to "hold," despite the broader analyst consensus remaining a "moderate buy" with an average price target of $456.72. The company reported quarterly EPS of $3.08, exceeding estimates, but revenue of $645.1 million, an 8.2% year-over-year increase, missed forecasts. Shares opened at $378.79 with a P/E ratio of 50.24, and COO Jeffrey Puckett sold 8,500 shares, reducing his position by over 52%.

Earnings
MarketBeat • Sep 4, 2026
Seaport Research Partners Upgrades Devon Energy (NYSE:DVN) to Strong-Buy

Seaport Research Partners has upgraded Devon Energy (NYSE:DVN) to a "strong-buy" rating, contributing to the stock's overall "Moderate Buy" consensus rating among analysts, with an average price target of $59.23. The company recently exceeded Q2 earnings expectations, reporting $1.57 EPS against an estimated $1.40, and revenue surged 73.1% year-over-year to $7.42 billion. DVN shares opened at $48.73, and institutional investors and hedge funds hold a significant 69.72% stake in the company.

Markets
Investing.com UK • Sep 4, 2026
ResMed chairman emeritus Peter Farrell sells $227,688 in stock By Investing.com

Peter C. Farrell, chairman emeritus of ResMed Inc. (NASDAQ:RMD), sold 970 shares of company stock for $227,688 on September 2, 2026, under a pre-arranged trading plan. Following the sale, Farrell directly holds 51,803 shares. The transaction occurs as ResMed, valued at $33.1 billion, is considered undervalued by InvestingPro analysis, despite recent mixed earnings and analyst sentiments.

Markets
Trefis • Sep 4, 2026
Royal Caribbean Stock Slides 9.4% Over 8 Straight Down Days

Royal Caribbean (RCL) stock has experienced an 8-day losing streak, dropping 9.4% and reducing its market value by $7.4 billion. Despite this decline, which appears specific to the company and not the broader market, RCL's fundamentals, such as its P/E multiple and operating margin, are favorable compared to the S&P 500 median. The article suggests this streak is a signal to re-evaluate the business and emphasizes the importance of diversification to mitigate single-stock risk.

Earnings
Investing.com • Sep 4, 2026
Docusign stock price target raised to $60 by Wells Fargo on IAM growth

Wells Fargo has increased its price target for Docusign Inc. (NASDAQ:DOCU) to $60 from $55, maintaining an "Equal Weight" rating, driven by growth in Intelligent Agreement Management (IAM) and strong Q2 revenue performance. Despite the upgrade, the stock trades higher at $65.97, and InvestingPro analysis suggests it remains undervalued. DocuSign's Q2 2027 adjusted EPS and revenue also surpassed Wall Street expectations, leading Evercore ISI and Citizens to reiterate positive ratings.

Earnings
MarketBeat • Sep 4, 2026
Tudor Financial Inc. Sells 5,697 Shares of Amgen Inc. $AMGN

Tudor Financial Inc. reduced its stake in Amgen Inc. by 36.8% during the second quarter, selling 5,697 shares and retaining 9,784 shares valued at $3.54 million. Despite institutional ownership of 76.5%, analysts maintain a "Hold" consensus on Amgen with a target price of $380.43, even as some individual targets have been raised. Amgen reported strong Q2 earnings, surpassing expectations with $6.29 EPS and $10.05 billion in revenue, and declared a quarterly dividend of $2.52 per share.

Earnings
MarketBeat • Sep 4, 2026
Raiffeisen Bank International AG Boosts Stock Position in Analog Devices, Inc. $ADI

Raiffeisen Bank International AG increased its stake in Analog Devices, Inc. (NASDAQ:ADI) by 25.8% in Q2, bringing its total holdings to 15,089 shares valued at $5.9 million. Institutional investors now own 86.81% of the company, and Wall Street analysts maintain a "Buy" rating with a consensus price target of $454.63. Analog Devices reported strong Q2 earnings with EPS of $3.45 and revenue of $4.02 billion, also declaring a quarterly dividend of $1.10 per share.

Earnings
MarketBeat • Sep 4, 2026
Raiffeisen Bank International AG Has $7.13 Million Holdings in Iron Mountain Incorporated $IRM

Raiffeisen Bank International AG reduced its stake in Iron Mountain Incorporated (NYSE:IRM) by 37.4% in the second quarter, now holding 54,892 shares valued at approximately $7.13 million. Iron Mountain reported strong quarterly revenue of $2.03 billion, an 18.5% year-over-year increase, and an EPS of $0.60, surpassing analyst estimates. Despite positive analyst ratings and a recent dividend declaration, insider selling and a high earnings multiple raise some concerns.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.